Stories by: ABN Staff

The cervical cancer vaccine Gardasil will be available to 12 to 13-year-old girls next year after manufacturer CSL and the federal government agreed on price.

Adult stem cell company Mesoblast has had filed an Investigational New Drug submission (IND) to the United States Food and Drug Administration (FDA) to commence a clinical trial of its allogeneic, or 'off-the-shelf', adult stem cells for spinal fusion.

Prana Biotechnology has raised $7.8 million in cash to add to its fund for a Phase IIa trial in human patients of its PBT2 compound for Alzheimer's disease.

The federal government has launched an internet tool for the biotechnology industry to help it navigate Australia's biotechnology regulations.

Melbourne company Mesoblast has announced positive results from preclinical trials of its patented adult stem cells injected by catheter directly into damaged heart muscle of sheep after a heart attack.

Drug maker Merck & Co has won another lawsuit over its Vioxx painkiller.

A prototype device that could enable both DNA and protein identification and measurement in a single sample at the same time has received the backing of US giant Applied Biosystems.

Scientists at Melbourne's Howard Florey Institute have shown that physical exercise alone can delay onset of memory loss in Huntington's disease (HD), but a combination of mental and physical exercise is more beneficial in delaying the fatal genetic disease's symptoms.

Scientists at Melbourne's Howard Florey Institute have shown that physical exercise alone can delay onset of memory loss in Huntington's disease (HD), but a combination of mental and physical exercise is more beneficial in delaying the fatal genetic disease's symptoms.

Researchers have found a highly unusual distribution of two proteins in the lungs and airways of people with cystic fibrosis, a discovery that could be a step in determining how the disease progresses.